Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France
试验速览
- 阶段
- 不适用
- 入组人数
- 306
- 试验地点
- 1
- 主要终点
- overall survival
研究概览
简要总结
Neuroendocrine cancer remains a poorly known entity. Comprehensive treatment is multidisciplinary involving surgery, radiological and nuclear medicine, and medical. A national network for the management of sporadic and hereditary malignant neuro-ENdocrine Tumor (RENATEN) is in charged of coordinating this specific care. This is part of the French National Cancer INstitute (INCa) Rare Cancer Plan.
The project is in the form of an analysis of elderly population (75 years or over) with a diagnosis of neuroendocrine cancer in the western part of the France (Brittany, Pays de Loire, Normandy, Center and a part of New Aquitaine areas) representing a population of more than 12 millions of inhabitants. Oncogeriatric evaluations, specialized meetings, ...would be analysed in order to improve the care of rare cancer patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 75 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •75 years old or over at the time of diagnosis
- •Patient with G1/G2/G3 neuroendocrine tumor diagnosed by pathological analysis
- •Patient whose medical file was examined by RENATEN (National Network for the treatment of neuro-ENdocrine sporadic and hereditary disease Tumor) meetings or other multidisciplinary consultation meeting between 01/01/2014 and 31/12/2017
- •Patient with care in private and public centers in the West of France
排除标准
- •Patient with cancer other than a neuroendocrine tumor
- •Patient with a G4 neuroendocrine tumor
- •Patient who has objected to the study and collection of his medical data
- •Refusal of participation
结局指标
主要结局
overall survival
时间窗: 03/31/2020
statistical analysis (months) with Kaplan meier analysis; data provided by the medical file
mitotic index and proliferation idex of the tumor
时间窗: 03/31/2020
statistical analysis (%)
Response rate
时间窗: 03/31/2020
statistical analysis (%)
Histology, differentiation status
时间窗: 03/31/2020
qualitative description (text)
All anticancer treatment description in neuroendocrine tumors of 3 specific histological grade (G1, 2 or 3)
时间窗: 03/31/2020
statistical analysis (%)
progression free survival
时间窗: 03/31/2020
statistical analysis (months) with Kaplan meier analysis; data provided by the medical file
Tumor description : localization of the tumor (digestive or others) provided by scan or anatomopathologic report
时间窗: 03/31/2020
statistical analysis (%)
次要结局
未报告次要终点